121 related articles for article (PubMed ID: 16875606)
1. SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression.
Hoelscher M; Richter N; Melle C; von Eggeling F; Schaenzer A; Nestler U
Neurol Res; 2013 Dec; 35(10):993-1001. PubMed ID: 24225180
[TBL] [Abstract][Full Text] [Related]
2. Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study.
Garrisi VM; Tufaro A; Trerotoli P; Bongarzone I; Quaranta M; Ventrella V; Tommasi S; Giannelli G; Paradiso A
PLoS One; 2012; 7(11):e49631. PubMed ID: 23226214
[TBL] [Abstract][Full Text] [Related]
3. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome.
Kang X; Xu Y; Wu X; Liang Y; Wang C; Guo J; Wang Y; Chen M; Wu D; Wang Y; Bi S; Qiu Y; Lu P; Cheng J; Xiao B; Hu L; Gao X; Liu J; Wang Y; Song Y; Zhang L; Suo F; Chen T; Huang Z; Zhao Y; Lu H; Pan C; Tang H
Clin Chem; 2005 Jan; 51(1):56-64. PubMed ID: 15550479
[TBL] [Abstract][Full Text] [Related]
4. Proteomic studies in breast cancer (Review).
Qin XJ; Ling BX
Oncol Lett; 2012 Apr; 3(4):735-743. PubMed ID: 22740985
[TBL] [Abstract][Full Text] [Related]
5. Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach.
He M; Qin J; Zhai R; Wei X; Wang Q; Rong M; Jiang Z; Huang Y; Zhang Z
Proteome Sci; 2008 Mar; 6():10. PubMed ID: 18331625
[TBL] [Abstract][Full Text] [Related]
6. Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.
Kabbage M; Chahed K; Hamrita B; Guillier CL; Trimeche M; Remadi S; Hoebeke J; Chouchane L
J Biomed Biotechnol; 2008; 2008():564127. PubMed ID: 18401453
[TBL] [Abstract][Full Text] [Related]
7. Altered proteomic polymorphisms in the caterpillar body and stroma of natural Cordyceps sinensis during maturation.
Dong YZ; Zhang LJ; Wu ZM; Gao L; Yao YS; Tan NZ; Wu JY; Ni L; Zhu JS
PLoS One; 2014; 9(10):e109083. PubMed ID: 25310818
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics of breast cancer.
Baskın Y; Yiğitbaşı T
Curr Genomics; 2010 Nov; 11(7):528-36. PubMed ID: 21532837
[TBL] [Abstract][Full Text] [Related]
9. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
11. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
12. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
13. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
14. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
15. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
